Literature DB >> 27856454

Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.

Xingjuan Chen1, Shaomin Qian1, April Hoggatt1, Hongying Tang1, Timothy A Hacker1, Alexander G Obukhov1, Paul B Herring1, Cheikh I Seye2.   

Abstract

OBJECTIVE: Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE-/-) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis. APPROACH AND
RESULTS: EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5'-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE-/- background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE-/- mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE-/- mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants.
CONCLUSIONS: EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE-/- mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  adenosine 5’-trisphosphate; atherosclerosis; endothelial cell; receptor; smooth muscle cell

Mesh:

Substances:

Year:  2016        PMID: 27856454      PMCID: PMC5268079          DOI: 10.1161/ATVBAHA.116.308561

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

1.  Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.

Authors:  Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 2.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

3.  P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Authors:  Timo Rieg; Maria Gerasimova; José L Boyer; Paul A Insel; Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

4.  P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction.

Authors:  ShengPeng Wang; András Iring; Boris Strilic; Julián Albarrán Juárez; Harmandeep Kaur; Kerstin Troidl; Sarah Tonack; Joachim C Burbiel; Christa E Müller; Ingrid Fleming; Jon O Lundberg; Nina Wettschureck; Stefan Offermanns
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

5.  Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells.

Authors:  R Malam-Souley; C Seye; A P Gadeau; G Loirand; X Pillois; M Campan; P Pacaud; C Desgranges
Journal:  J Cell Physiol       Date:  1996-01       Impact factor: 6.384

6.  Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells.

Authors:  Cleide Gonçalves da Silva; Anke Specht; Barbara Wegiel; Christiane Ferran; Elzbieta Kaczmarek
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

7.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.

Authors:  J A Panza; C E García; C M Kilcoyne; A A Quyyumi; R O Cannon
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

8.  Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells.

Authors:  D Erlinge; J You; C Wahlestedt; L Edvinsson
Journal:  Eur J Pharmacol       Date:  1995-03-15       Impact factor: 4.432

Review 9.  The role of endothelium in cardiovascular homeostasis and diseases.

Authors:  G M Rubanyi
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105

10.  Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation.

Authors:  Shaomin Qian; April Hoggatt; Yava L Jones-Hall; Carl F Ware; Paul Herring; Cheikh I Seye
Journal:  Vascul Pharmacol       Date:  2016-06-26       Impact factor: 5.773

View more
  17 in total

1.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

2.  Updates on Approaches for Studying Atherosclerosis.

Authors:  Congqing Wu; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 3.  Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.

Authors:  Xian-Ming Wu; Ning Zhang; Jiang-Shan Li; Zhi-Hong Yang; Xiao-Lou Huang; Xiao-Fang Yang
Journal:  Purinergic Signal       Date:  2022-01-03       Impact factor: 3.765

Review 4.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

Review 5.  The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.

Authors:  Cendrine Cabou; Laurent O Martinez
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

6.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 7.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

8.  Piezo1 and Gq/G11 promote endothelial inflammation depending on flow pattern and integrin activation.

Authors:  Julián Albarrán-Juárez; Andras Iring; ShengPeng Wang; Sayali Joseph; Myriam Grimm; Boris Strilic; Nina Wettschureck; Till F Althoff; Stefan Offermanns
Journal:  J Exp Med       Date:  2018-09-07       Impact factor: 14.307

Review 9.  Purinergic Regulation of Endothelial Barrier Function.

Authors:  Muhammad Aslam; Dursun Gündüz; Christian Troidl; Jacqueline Heger; Christian W Hamm; Rainer Schulz
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 10.  P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

Authors:  Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.